A major breakthrough in 2025 is the escalating utilization of repurposed medicine—drugs initially designed for non-cancer conditions but now displaying promise in oncology. Drugs like ivermectin, mebendazole, and fenbendazole, traditionally utilized as antiparasitic brokers, are now being researched for their anticancer Attributes. 7. Highly developed Prostate Cancer Hormone-concentra... https://andtreatmentsin202517406.wikigop.com/1755051/and_treatments_in_2025_fundamentals_explained